Co-Founder & Chief Executive Officer
Roger Dawson is one of the founders and Chief Executive Officer of Linkster Therapeutics.
Roger has over 11 years of experience in research and drug development working at F.Hoffmann-La Roche. He contributed to the advancement of drug molecules as team player and leader of international and cross-functional teams. Inter alia, Roger served as head of translational protein science, project leader and implemented Roche’s ‘membrane protein platform’. As a renowned drug discovery expert, he lead-authored numerous publications in the GPCR, ion channel and transporter field.
Roger holds a masters degree in Chemistry from the TUM and obtained his PhD in Biology at the ETH Zurich. He was awarded Roche’s RPF fellowship and the Swiss Federal Center of Technology and Innovation (Innosuisse) program.